These results demonstrated another benefit of G-CSF treatment for lupus nephritis, because CD25-Foxp3+ T cells were increased in the case of active lupus nephritis and had lower suppressive activity than CD25+Foxp3+ Tregs [31, 32]. This evidence concerns the gene FOXP3 and lupus nephritis.